Regeneron, Colorado Center for Personalized Medicine Enter Broad Genetics Research Collaboration

Genomic data will be paired with de-identified health records from CCPM to aid in genomic medicine, drug discovery, and personalized medicine approaches, which the partners foresee enabling precision medicine.

New Method for RNA-Seq Helps Unravel Data from a Mixture of People

The technique could help study how genetic variants in different people affect which genes are expressed during infection or response to drugs ,and could also increase efficiency of single-cell experiments, assisting research into transplants, personalized medicine, and malaria.
New data describes the economic impact of genomic sequencing procedures. [NIH]

GA4GH Details its COVID-19 Patient Data Sharing, Privacy Recommendations

GA4GH says its goal is to summarize key regulatory pathways, particularly providing information on health research regulation and ethical/legal data governance, including possible modification for genomic researchers in a public health emergency.
Illustration of a cancer cell

Indivumed Launches Global Personalized Oncology Alliance

The Alliance, dubbed Onco AI-Med, will make use of Indivumed's multi-omics database, IndivuType, to accelerate new insights into the personalized treatment of cancer.

New Approach Makes Polygenic Scores More Applicable to People of Multiple Ethnic Origins

The researchers used a combination of local ancestry deconvolution and partial polygenic score computation to account for the population-specific nature of association signals in individuals with admixed ancestry.

Largest Study to Date of COVID-19 Susceptibility Launched

Researchers will launch the study involving 1,000 subjects—consisting of COVID-19 patients and their partners and first-degree relatives as controls—to compare a variety of genomic and other biological variables between those patients who show no or mild symptoms and those who show severe illness.
Internet network

Prototype Tool Leverages AI to Predict Which COVID-19 Patients Most Likely to Develop Severe...

The tool indicated that a combination of small changes in levels of the liver enzyme alanine aminotransferase (ALT), patient-reported myalgia (aching muscles), and raised hemoglobin levels, most accurately predicted the development severe disease.

New Institute to Seek AI-Based Solutions to Curbing COVID-19 Pandemic

C3.ai DTI will focus its research on AI, machine learning, the internet of things, big data analytics, human factors, organizational behavior, ethics, and public policy.
Data Medicine

Clinical Combinations

Clinicians pursue combining genotypes with phenotypes to provide more precise healthcare.
Human microbiome, conceptual illustration

Novel Microbiome Data Search Method Aids Disease Diagnosis

Search method’s two-step process to identify disease first searches a baseline database of healthy individuals to detect any specific microbiome outlier novelty, then searches for that outlier in a database of disease-specific examples.
Scroll Up